Related Experiment Video
Updated: May 15, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
Published on: July 28, 2010
Alteration of the DNA damage response in colorectal tumor progression
Hiroaki Takabayashi1, Toshifumi Wakai, Yoichi Ajioka
1Division of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan.
Abstract:
Recent studies have demonstrated increased levels of DNA double-strand breaks (DSBs) and activation of the DNA damage response (DDR) in precancerous lesions during cancer development. Those observations have not been fully elucidated using paraffin-embedded tissues of colorectal tumors. The aims of this study were to analyze the presence of DSBs and DDR activation mediated by p53-binding protein 1 (53BP1), which is a conserved checkpoint and DNA repair protein, and to clarify their association with colorectal tumor progression. We used immunohistochemical staining to investigate the expression of γH2AX, a sensitive marker for DSBs, in 152 colorectal tumors (46 low-grade adenomas, 25 high-grade adenomas, 25 intramucosal carcinomas, and 56 invasive carcinomas). The colocalization of γH2AX and 53BP1, which is strongly associated with the DSB repair process, was analyzed using double-label immunofluorescence. Elevated γH2AX expression was identified in 16 (16.7%) of 96 intramucosal neoplasias and in 19 (33.9%) of 56 invasive carcinomas. Double-label immunofluorescence occasionally revealed cells, particularly in invasive carcinoma, with γH2AX foci that did not colocalize with 53BP1. The percentage of tumor cells with γH2AX foci that colocalized with 53BP1 was significantly lower in invasive carcinoma than in intramucosal neoplasia (median percentage, 54.8% and 88.5%, respectively; P = .001). In conclusion, the number of cells with DSBs increases in intramucosal neoplasia and invasive carcinoma. The decreasing number of cells with colocalization of γH2AX and 53BP1 during the progression from intramucosal neoplasia to invasive carcinoma suggests that DDR, at least mediated by 53BP1, is inefficient during the process of cancer invasion.
Insights
DNA double-strand breaks (DSBs) and DNA damage response (DDR) increase during colorectal cancer progression. However, the DDR mediated by p53-binding protein 1 (53BP1) becomes less efficient in invasive colorectal cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- DNA double-strand breaks (DSBs) and activation of the DNA damage response (DDR) are observed in precancerous lesions.
- These phenomena require further elucidation in colorectal tumor tissues.
Purpose of the Study:
- To analyze DSBs and DDR activation mediated by p53-binding protein 1 (53BP1) in colorectal tumors.
- To clarify the association between DSBs, DDR activation, and colorectal tumor progression.
Main Methods:
- Immunohistochemical staining for γH2AX (DSB marker) in 152 colorectal tumors.
- Double-label immunofluorescence for γH2AX and 53BP1 colocalization analysis.
Main Results:
- Elevated γH2AX expression was found in intramucosal neoplasias (16.7%) and invasive carcinomas (33.9%).
- The percentage of tumor cells with colocalized γH2AX and 53BP1 foci was significantly lower in invasive carcinoma (54.8%) compared to intramucosal neoplasia (88.5%).
Conclusions:
- The number of cells with DSBs increases during colorectal tumor progression.
- Inefficient DDR, particularly mediated by 53BP1, is suggested during colorectal cancer invasion.
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Nucleotide Excision Repair

